These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 9226737)

  • 21. Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal.
    Rassnick S; Heinrichs SC; Britton KT; Koob GF
    Brain Res; 1993 Mar; 605(1):25-32. PubMed ID: 8467387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversal of increased anxiety during benzodiazepine withdrawal: evidence for an anxiogenic endogenous ligand for the benzodiazepine receptor.
    Baldwin HA; File SE
    Brain Res Bull; 1988 May; 20(5):603-6. PubMed ID: 2838131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fetal ethanol effects on benzodiazepine sensitivity measured by behavior on the elevated plus-maze.
    Osborn JA; Yu C; Gabriel K; Weinberg J
    Pharmacol Biochem Behav; 1998 Jul; 60(3):625-33. PubMed ID: 9678645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flumazenil induces benzodiazepine partial agonist-like effects in BALB/c but not C57BL/6 mice.
    Belzung C; Le Guisquet AM; Crestani F
    Psychopharmacology (Berl); 2000 Jan; 148(1):24-32. PubMed ID: 10663414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intra-periaqueductal gray matter injections of midazolam fail to alter anxiety in plus-maze experienced mice.
    dos Reis LM; Canto-de-Souza A
    Brain Res; 2008 Sep; 1231():93-102. PubMed ID: 18621039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prenatal ethanol exposure alters sensitivity to the effects of corticotropin-releasing factor (CRF) on behavior in the elevated plus-maze.
    Gabriel KI; Yu CL; Osborn JA; Weinberg J
    Psychoneuroendocrinology; 2006 Oct; 31(9):1046-56. PubMed ID: 16934947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of the benzodiazepine antagonist flumazenil on conditioned fear stress in rats.
    Izumi T; Inoue T; Tsuchiya K; Hashimoto S; Ohmori T; Koyama T
    Prog Neuropsychopharmacol Biol Psychiatry; 1999 Oct; 23(7):1247-58. PubMed ID: 10581646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anxiolytic-like effects of the corticotropin-releasing factor1 (CRF1) antagonist DMP904 [4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1,5-a]-pyrimidine] administered acutely or chronically at doses occupying central CRF1 receptors in rats.
    Lelas S; Wong H; Li YW; Heman KL; Ward KA; Zeller KL; Sieracki KK; Polino JL; Godonis HE; Ren SX; Yan XX; Arneric SP; Robertson DW; Hartig PR; Grossman S; Trainor GL; Taub RA; Zaczek R; Gilligan PJ; McElroy JF
    J Pharmacol Exp Ther; 2004 Apr; 309(1):293-302. PubMed ID: 14742750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization in rats of the anxiolytic potential of ELB139 [1-(4-chlorophenyl)-4-piperidin-1-yl-1,5-dihydro-imidazol-2-on], a new agonist at the benzodiazepine binding site of the GABAA receptor.
    Langen B; Egerland U; Bernöster K; Dost R; Unverferth K; Rundfeldt C
    J Pharmacol Exp Ther; 2005 Aug; 314(2):717-24. PubMed ID: 15860576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methanol extract of semen Ziziphi Spinosae attenuates ethanol withdrawal anxiety by improving neuropeptide signaling in the central amygdala.
    Li LB; Kim YW; Wang YH; Bai L; Zhu XD; Zhao ZL; Lee CW; Jiao Y; Wu T; Cai ZZ; Kim SC; An WG; Yang CH; Cui GC; Zhao RJ
    BMC Complement Altern Med; 2019 Jun; 19(1):147. PubMed ID: 31234859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sensitization, duration, and pharmacological blockade of anxiety-like behavior following repeated ethanol withdrawal in adolescent and adult rats.
    Wills TA; Knapp DJ; Overstreet DH; Breese GR
    Alcohol Clin Exp Res; 2009 Mar; 33(3):455-63. PubMed ID: 19120055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat.
    Pellow S; File SE
    Pharmacol Biochem Behav; 1986 Mar; 24(3):525-9. PubMed ID: 2871560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-anxiety effects of Apocynum venetum L. in the elevated plus maze test.
    Grundmann O; Nakajima J; Seo S; Butterweck V
    J Ethnopharmacol; 2007 Apr; 110(3):406-11. PubMed ID: 17101250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A theory of benzodiazepine dependence that can explain whether flumazenil will enhance or reverse the phenomena.
    File SE; Hitchcott PK
    Psychopharmacology (Berl); 1990; 101(4):525-32. PubMed ID: 1975108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prior multiple ethanol withdrawals enhance stress-induced anxiety-like behavior: inhibition by CRF1- and benzodiazepine-receptor antagonists and a 5-HT1a-receptor agonist.
    Breese GR; Overstreet DH; Knapp DJ; Navarro M
    Neuropsychopharmacology; 2005 Sep; 30(9):1662-9. PubMed ID: 15726114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Participation of GABA--benzodiazepine receptor complex in the anxiolytic effect of piracetam].
    Moldavkin GM; Voronina TA; Neznamov GG; Maletova OK; Eliava NV
    Eksp Klin Farmakol; 2006; 69(3):7-9. PubMed ID: 16878489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Flumazenil blocks the anxiolytic action of allopregnanolone.
    Fernández-Guasti A; Picazo O
    Eur J Pharmacol; 1995 Jul; 281(1):113-5. PubMed ID: 8566110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Flumazenil but not nitrendipine reverses the increased anxiety during ethanol withdrawal in the rat.
    File SE; Baldwin HA; Hitchcott PK
    Psychopharmacology (Berl); 1989; 98(2):262-4. PubMed ID: 2502796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enkephalin analog, cyclo[N(ε),N(β)-carbonyl-D-Lys(2),Dap(5)] enkephalinamide (cUENK6), inhibits the ethanol withdrawal-induced anxiety-like behavior in rats.
    Gibula-Bruzda E; Marszalek-Grabska M; Witkowska E; Izdebski J; Kotlinska JH
    Alcohol; 2015 May; 49(3):229-36. PubMed ID: 25716198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The anxiolytic-like effects of the neurosteroid allopregnanolone: interactions with GABA(A) receptors.
    Brot MD; Akwa Y; Purdy RH; Koob GF; Britton KT
    Eur J Pharmacol; 1997 Apr; 325(1):1-7. PubMed ID: 9151931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.